Browsing by Author Scurr, Lyndee

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2012Absence of Distinguishing Senescence Traits in Human Melanocytic NeviBecker, Therese; Gowrishankar, Kavitha; Kefford, Richard (Rick); Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Thompson, John; Tran, Sieu; Desilva, Chitra; Haferkamp, Sebastian; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgery; Western Clinical School: Medicine (Westmead)Absence of Distinguishing Senescence Traits in Human Melanocytic Nevi, The Journal of Investigative Dermatology, vol.132, 9, 2012,pp 2226-2234
2008Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerBalleine, Rosemary; Chiew, Yoke-Eng; deFazio, Anna; Guminski, Alexander; Harnett, Paul; Kennedy, Catherine Jane; Lei, Ying; Pryor, Kylie; Rizos, Helen; Scurr, Lyndee; Brand, Alison; Byth, Karen; Sharma, Raghwa; Wain, Gerard V.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Obstetrics & Gynaecology; Western Clinical School: Westmead Millennium Institute; Medicine Faculty Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian Cancer, Clinical Cancer Research, vol.14, 21, 2008,pp 6924-6932
2009The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4aBecker, Therese; Diefenbach, Eve; Dijkstra, Menno; Frausto, Monika; Haferkamp, Sebastian; Kefford, Richard (Rick); Mann, Graham; Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Reisman, David N.; Western Clinical School: Westmead Millennium Institute; Sydnovate; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a, Molecular Cancer, vol.8,(4),2009,pp 4-1-4-12
2008The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitrode Fazio, Anna; Murali, Rajmohan; Scolyer, Richard; Scurr, Lyndee; Barton, C; Davies, Michael; et, al; Gloss, B; Henderson, Michelle; O'Brien, P; Patterson, K I; Saunders, D; Scurry, J; Smith, Alison N.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro, British Journal of Cancer, vol.98,(6),2008,pp 1085-1093
2010IGFBP7 is not required for B-RAF-induced melanocyte senescenceBecker, Therese; Haferkamp, Sebastian; Irvine, Malama; Kefford, Richard (Rick); Mann, Graham; Pupo, Gulietta; Rizos, Helen; Scolyer, Richard; Scurr, Lyndee; Becker, Jurgen; Lai, Ken; Schrama, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Pathology; Western Clinical School: Medicine (Westmead)IGFBP7 is not required for B-RAF-induced melanocyte senescence, Cell, vol.141, 4,pp 717-727
2014The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanomaBecker, Therese; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Todd, James; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Molecular BioscienceThe MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma, Oncogene, vol.33, 2, 2014,pp 236-245
2009Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor SuppressorsBecker, Therese; Frausto, Monika; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Oncogene-Induced Senescence Does Not Require the p16INK4a or p14ARF Melanoma Tumor Suppressors, The Journal of Investigative Dermatology, vol.129, 8, 2009,pp 1983-1991
2007p14ARF Regulates E2F-1 Ubiquitination and Degradation via a p53-Dependent MechanismAlling, Nikki; Irvine, Malama; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)p14ARF Regulates E2F-1 Ubiquitination and Degradation via a p53-Dependent Mechanism, Cell Cycle, vol.6, 14, 2007,pp 1741-1747
2008p16(INK4a)-induced senescence is disabled by melanoma-associated mutationsBecker, Therese; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)p16(INK4a)-induced senescence is disabled by melanoma-associated mutations, Aging Cell, vol.7, 5, 2008,pp 733-745
2008p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumorsDunleavey, Ruth; Gallagher, Stuart; Gao, Bo-Fu; Indsto, James; Kefford, Richard (Rick); Mann, Graham; Rizos, Helen; Scurr, Lyndee; Thompson, John; Lett, Margaret; Western Clinical School (Westmead): Office; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: Surgeryp16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors, NeoPlasia: an international journal of oncology research, vol.10, 11, 2008,pp 1231-1239
2011P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferationRizos, Helen; Scurr, Lyndee; Ashton, katie A.; Avery-Kiejda, Kelly A; Bowden, Nikola; Croft, A.; Hersey, Peter; Kairupan, Carla F.; Scott, Rodney J.; Talseth-Palmer, Bente A.; Zhang, XD; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation, BMC Cancer, vol.11, 203, 2011,pp 1-17
2006Physical and functional interaction of the p14ARF tumor suppressor with ribosomes.Ayub, Ana; Becker, Therese; Kefford, Richard (Rick); McKenzie, Heather; Rizos, Helen; Scurr, Lyndee; Woodruff, Sarah; Stahl, Joachim; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Physical and functional interaction of the p14ARF tumor suppressor with ribosomes., Journal of Biological Chemistry, vol.281,(49),2006,pp 38080-38088
2009The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescenceBecker, Therese; Haferkamp, Sebastian; Kefford, Richard (Rick); Rizos, Helen; Scurr, Lyndee; Tran, Sieu; Western Clinical School: Westmead Millennium Institute; Western Clinical School (Westmead): Office; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence, Aging, vol.1, 6,pp 542-556
2006Retinal light damage: Structural and functional effects of the antioxidant glutathione peroxidase-1.Scurr, Lyndee; de Haan, Judy B.; Favilla, Ian; Gosbell, Andrew D.; Kola, Ismail; Pete, Josefa; Stefanovic, Nada; Western Clinical School: Medicine (Westmead)Retinal light damage: Structural and functional effects of the antioxidant glutathione peroxidase-1., Investigative Ophthalmology & Visual Science, vol.47,(6),2006,pp 2613-2622